Sirio Pharma Co.,Ltd.’s Net Profit Rose 28.1% in First Quarter of 2023

Sirio Pharma Co.,Ltd. (仙乐健康科技股份有限公司) (300791.SZ) reported a net profit of 18.8 million yuan in the first quarter of 2023, up 28.1% year-on-year.

Meanwhile, the company posted 702.2 million yuan in revenue, up 66.7% year-on-year.

At the end of the reporting period, it had 4.7 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 39%.